ITEM 1. FINANCIAL STATEMENTS
HUAIZHONG HEALTH GROUP, INC.
INDEX TO UNAUDITED INTERIM FINANCIAL STATEMENTS
FOR THE PERIOD ENDED JANUARY 31, 2022
HUAIZHONG HEALTH GROUP, INC.
Balance Sheets
(Unaudited)
| | January 31, | | | October 31, | |
| | 2022 | | | 2021 | |
ASSETS | | | | | | |
Current Assets | | | | | | |
Cash | | $ | - | | | $ | - | |
Total Current Assets | | | - | | | | - | |
| | | | | | | | |
Total Assets | | $ | - | | | $ | - | |
| | | | | | | | |
Liabilities and Stockholders' Deficit | | | | | | | | |
Current Liabilities | | | | | | | | |
Accounts payable and accrued liabilities | | | 10,000 | | | | 9,950 | |
Due to related party | | | 50,026 | | | | 40,351 | |
Total Current Liabilities | | | 60,026 | | | | 50,301 | |
| | | | | | | | |
Total Liabilities | | | 60,026 | | | | 50,301 | |
| | | | | | | | |
Stockholders' Deficit | | | | | | | | |
Common stock: 750,000,000shares authorized; $0.001par value | | | | | | | | |
31,518,466issued and outstanding | | | 31,518 | | | | 31,518 | |
Additional paid in capital | | | 257,587 | | | | 257,587 | |
Accumulated deficit | | | (349,131 | ) | | | (339,406 | ) |
Total Stockholders' Deficit | | | (60,026 | ) | | | (50,301 | ) |
Total Liabilities and Stockholders' Deficit | | $ | - | | | $ | - | |
The accompanying notes to the unaudited financial statements are an integral part of these statements.
HUAIZHONG HEALTH GROUP, INC.
Statements of Operations
(Unaudited)
| | Three Months Ended | |
| | January 31, | |
| | 2022 | | | 2021 | |
| | | | | | |
Revenue | | $ | - | | | $ | - | |
| | | | | | | | |
Operating Expenses: | | | | | | | | |
Professional fees | | | 9,725 | | | | 9,610 | |
General and administrative | | | - | | | | 1,675 | |
Total operating expenses | | | 9,725 | | | | 11,285 | |
| | | | | | | | |
Operating Loss | | | (9,725 | ) | | | (11,285 | ) |
| | | | | | | | |
Net loss before taxes | | | (9,725 | ) | | | (11,285 | ) |
| | | | | | | | |
Income tax benefit | | | - | | | | - | |
| | | | | | | | |
Net Loss | | $ | (9,725 | ) | | $ | (11,285 | ) |
| | | | | | | | |
Net loss per common share, basic and diluted | | $ | (0.0003 | ) | | $ | (0.0004 | ) |
Basic and diluted weighted average common shares outstanding | | | 31,518,466 | | | | 31,518,466 | |
The accompanying notes to the unaudited financial statements are an integral part of these statements.
HUAIZHONG HEALTH GROUP, INC.
Statements of Changes in Stockholders’ Deficit
(Unaudited)
For the Three Months Ended January 31, 2022
| | | | | | | | Additional | | | | | | | |
| | Common Stock | | | Paid in | | | Accumulated | | | | |
| | Shares | | | Amount | | | Capital | | | Deficit | | | Total | |
Balance - October 31, 2021 | | | 31,518,466 | | | $ | 31,518 | | | $ | 257,587 | | | $ | (339,406 | ) | | $ | (50,301 | ) |
| | | | | | | | | | | | | | | | | | | | |
Net loss | | | - | | | | - | | | | - | | | | (9,725 | ) | | | (9,725 | ) |
Balance - January 31, 2022 | | | 31,518,466 | | | $ | 31,518 | | | $ | 257,587 | | | $ | (349,131 | ) | | $ | (60,026 | ) |
For the Three Months Ended January 31, 2021
| | | | | | | | Additional | | | | | | | |
| | Common Stock | | | Paid in | | | Accumulated | | | | |
| | Shares | | | Amount | | | Capital | | | Deficit | | | Total | |
Balance - October 31, 2020 | | | 31,518,466 | | | $ | 31,518 | | | $ | 257,587 | | | $ | (308,577 | ) | | $ | (19,472 | ) |
| | | | | | | | | | | | | | | | | | | | |
Net loss | | | - | | | | - | | | | - | | | | (11,285 | ) | | | (11,285 | ) |
Balance - January 31, 2021 | | | 31,518,466 | | | $ | 31,518 | | | $ | 257,587 | | | $ | (319,862 | ) | | $ | (30,757 | ) |
The accompanying notes to the unaudited financial statements are an integral part of these statements.
HUAIZHONG HEALTH GROUP, INC.
Statements of Cash Flows
(Unaudited)
| | Three Months Ended | |
| | January 31, | |
| | 2022 | | | 2021 | |
| | | | | | |
CASH FLOWS FROM OPERATING ACTIVITIES | | | | | | |
Net loss | | $ | (9,725 | ) | | $ | (11,285 | ) |
Changes in current assets and liabilities: | | | | | | | | |
Related party advances funding operations | | | 9,675 | | | | 12,188 | |
Accounts payable and accrued liabilities | | | 50 | | | | (903 | ) |
Net cash used in operating activities | | | - | | | | - | |
| | | | | | | | |
Net change in cash for the period | | | - | | | | - | |
Cash at beginning of period | | | - | | | | - | |
Cash at end of period | | $ | - | | | $ | - | |
| | | | | | | | |
SUPPLEMENTAL CASH FLOW INFORMATION: | | | | | | | | |
Cash paid for income taxes | | $ | - | | | $ | - | |
Cash paid for interest | | $ | - | | | $ | - | |
The accompanying notes to the unaudited financial statements are an integral part of these statements.
HUAIZHONG HEALTH GROUP, INC.
Notes to the Unaudited Financial Statements
January 31, 2021
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation of Unaudited Interim Financial Statements
The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.
In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended October 31, 2021, as filed with the SEC on January 26, 2022.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.
NOTE 2 - GOING CONCERN
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of January 31, 2022, the Company has suffered recurring losses from operations, has an accumulated deficit of $349,131 and has not earned any revenues. The Company intends to fund operations through equity financing arrangements and related party advances, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending October 31, 2022.
The ability of the Company to emerge from an early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings.
These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty
COVID-19
A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position as of January 31, 2022. The full extent of the future impacts of COVID-19 on the Company’s plan of operations is uncertain. A prolonged outbreak could have a material adverse impact on the Company’s ability to identify and implement new business opportunities and/or consummate an acceptable merger or acquisition transaction.
NOTE 3 - RELATED PARTY TRANSACTIONS
During the three months ended July 31,2022 and 2021, the Company’s sole officer advanced to the Company an amount of $9,675 and $12,188 by paying for expenses on behalf of the Company. As of January 31, 2022, and October 31, 2021, the Company was obligated to the officer, for an unsecured, non-interest-bearing demand loan with a balance of $50,026 and $40,351, respectively.
Other
The Company does not own or lease property or lease office space. The office space used by the Company was arranged by the CEO and President, of the Company to use at no charge.
NOTE 4 - SUBSEQUENT EVENTS
Management has evaluated subsequent events through the date these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
FORWARD-LOOKING STATEMENTS
This quarterly report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.
Our unaudited financial statements are prepared in accordance with United States Generally Accepted Accounting Principles. The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this quarterly report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this quarterly report.
In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to “common shares” refer to the common shares in our capital stock.
CERTAIN TERMS USED IN THIS REPORT
As used in this annual report, the terms “we”, “us”, “our”, “Huaizhong”, mean Huaizhong Health Group, Inc.”., unless the context clearly requires otherwise.
Item 1. Business
Overview
Huaizhong Heath Group, Inc. is a for profit corporation established under the corporation laws in the State of Nevada, United States of America on September 12, 2013, originally incorporated as Adaiah Distribution, Inc. Effective December 15, 2020, the company changed its name to Huaizhong Health Group, Inc. The Company’s fiscal year end is October 31.
The Company was in the development phase of its custom pillow distribution business. During the third fiscal quarter ending July 31, 2018, the Company had ceased its operations of its Pillow manufacturing and sales.
We have since changed our focus to looking for other business opportunities to implement and/or operating companies with which to engage in a business combination.
Our address is Tianan Technology Park, 13/F Headquarter, Center Building 16, 555 Panyu North Ave., Panyu District, Guangzhou City, China. Our telephone number is +86 (20) 2982-9356.
We have not ever declared bankruptcy, been in receivership, or involved in any kind of legal proceeding.
The following discussion should be read in conjunction with our financial statements, including the notes thereto, appearing elsewhere in this annual report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include but are not limited to those discussed below and elsewhere in this report. Our unaudited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.
COVID-19
A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position as of January 31, 2022. The full extent of the future impacts of COVID-19 on the Company’s plan of operations is uncertain. A prolonged outbreak could have a material adverse impact on the Company’s ability to identify and implement new business opportunities and/or consummate an acceptable merger or acquisition transaction.
Plan of Operations and Cash Requirements
We are no longer attempting to implement our original business plan. We now intend to look for other business opportunities to implement and/or operating companies with which to engage in a business combination. We do not intend, at this time, to restrict our focus to opportunities or business combinations in any specific industry. Instead our focus will be on achieving long-term growth potential.
The analysis of new business opportunities will be undertaken by or under the supervision of the Company’s management. While the Company has limited assets and no operating revenues, the Company has unrestricted flexibility in seeking, analyzing and participating in potential business opportunities and/or combinations in in any type of business, industry or geographical location. In its efforts, the Company will consider the following kinds of factors:
(a) potential for growth, indicated by new technology, anticipated market expansion or new products.
(b) competitive position as compared to other operations of similar size and experience within the industry segment as well as within the industry as a whole.
(c) strength and diversity of management, either in place or scheduled for recruitment.
(d) capital requirements and anticipated availability of required funds, to be provided by the Company or from operations, through the sale of additional securities, through joint ventures or similar arrangements or from other sources.
(e) the cost of participation by the Company as compared to the perceived tangible and intangible values and potentials.
(f) the extent to which the business opportunity can be advanced; and
(g) the accessibility of required management expertise, personnel, raw materials, services, professional assistance and other required items.
In applying the foregoing criteria, not one of which will be controlling, management will attempt to analyze all factors and circumstances and make a determination based upon reasonable investigative measures and available data. Potentially available opportunities may occur in many different industries, and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex. Due to the Registrant’s limited capital available for investigation, the Registrant may not discover or adequately evaluate adverse facts about the opportunity to be acquired. In addition, we will be competing against other entities that possess greater financial, technical and managerial capabilities for identifying and completing the implementation of any opportunities and/or business combinations.
Results of Operations
The following summary of our results of operations should be read in conjunction with our financial statements for the period ended January 31, 2022, which are included herein.
Our operating results for the three months ended January 31, 2022 and 2021 and the changes between those periods for the respective items are summarized as follows.
Results of Operations for the three months ended January 31, 2022 and 2021
| | Three Months Ended | | | | |
| | January 31, | | | | |
| | 2022 | | | 2021 | | | Change | |
Operating expenses | | | 9,725 | | | | 11,285 | | | | (1,560 | ) |
Net loss | | $ | 9,725 | | | $ | 11,285 | | | $ | (1,560 | ) |
During the three months ended January 31, 2022 and 2021, no operating revenues were recorded.
We had a net loss of $9,725 and $11,285 for the three months ended January 31, 2022 and 2021, respectively. The decrease in net loss of $1,560 was primarily due to a decrease in operating expenses of $1,560.
Operating expenses for the three months ended January 31, 2022 and 2021 were $9,725 and $11,285, respectively.
During the three months ended January 31,2022, the operating expenses, were primarily attributed to professional fees of $9,725, for maintaining reporting status with the Securities and Exchange Commission (“SEC”).
During the three months ended January 31, 2021, the operation expenses were primarily attributed to professional fees of $9,610 for maintaining reporting status with the Securities and Exchange Commission (“SEC”) and general administrative expenses of $1,675.
Balance Sheet Data:
| | January 31, | | | October 31, | | | | |
| | 2022 | | | 2021 | | | Change | |
Cash | | $ | - | | | $ | - | | | $ | - | |
Current Assets | | | - | | | | - | | | | - | |
Current Liabilities | | | 60,026 | | | | 50,301 | | | | 9,725 | |
Working Capital (Deficiency) | | $ | (60,026 | ) | | $ | (50,301 | ) | | $ | (9,725 | ) |
As of January 31, 2022, our current assets were $0, and our current liabilities were $60,026 which resulted in working capital deficiency of $60,026.
As of January 31, 2022, current liabilities were comprised of $10,000 in accounts payable and accrued liabilities, $50,026 in due to related party, compared to $9,950 in accounts payable and accrued liabilities, $40,351 in due to related party as of October 31, 2021.
As of January 31, 2022, our working capital deficiency increased by $9,725 from $50,301 on October 31, 2021, to $60,026 on January 31, 2022, primarily due to an increase in current liabilities of $9,725.
Cash Flow Data:
| | Three Months Ended | | | | |
| | January 31, | | | | |
| | 2022 | | | 2021 | | | Change | |
Cash used in operating activities | | $ | - | | | $ | - | | | $ | - | |
Cash provided by (used in) investing activities | | | - | | | | - | | | | - | |
Cash provided by financing activities | | | - | | | | - | | | | - | |
Net change in cash for period | | $ | - | | | $ | - | | | $ | - | |
Cash Flows from Operating Activities
We have not generated positive cash flows from operating activities. For the three months ended January 31, 2022, net cash flows used in operating activities was $0, consisting of a net loss of $9,725, reduced by an increase in accounts payable and accrued liabilities of $50 and expenses paid by related party of $9,675. For the three months ended January 31, 2021, net cash flows used in operating activities was $0, consisting of a net loss of $11,285, increased by an decrease in accounts payable and accrued liabilities of $903 and offset by an increase in expenses paid by related party of $12,188.
Cash Flows used in Investing Activities
During the three months years ended January 31, 2022 and 2021, we had no cash used in investing activities.
Cash Flows from Financing Activities
During the three months ended January 31, 2022 and 2021, we had no cash used in financing activities.
Going Concern
As of January 31, 2022, our Company had a net loss of $9,725 and has earned no operating revenues. Our Company intends to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending October 31, 2022. The ability of our Company to emerge from the development stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of our business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings or through debt financing. These factors, among others, raise substantial doubt about our Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Critical Accounting Policies
The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with the accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. We believe there are no material estimates or assumptions with levels of subjectivity and judgement necessary to be considered critical accounting policies.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.